Caprihans India Limited has received and forwarded a disclosure from its promoter, Bilcare Limited, pursuant to Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Transaction Details

  • Date of Conversion and Allotment: 02 June 2026
  • Number of Warrants Converted: 265,000 warrants
  • Number of Equity Shares Allotted: 265,000 equity shares of ₹10 each
  • Premium per Share: ₹190 per share
  • Total Consideration: ₹5,30,00,000 (₹5.30 crores)
  • Face Value: ₹26,50,000 (₹10 per share × 265,000 shares)
  • Premium Amount: ₹5,03,50,000 (₹190 per share × 265,000 shares)
  • Transaction Type: Conversion of warrants to equity shares (Buy)
  • Mode of Acquisition: Conversion of warrants allotted through Preferential Offer

Warrant Holding Pattern

Bilcare Limited originally held 580,000 convertible warrants in Caprihans India Limited. The conversion history is as follows:

| Tranche | Date | Warrants Converted | Equity Shares Allotted | Balance Warrants |

| Fourth | 02/06/2026 | 265,000 | 265,000 | 315,000 |

Shareholding Impact

The conversion has increased Bilcare Limited's shareholding in Caprihans India Limited:

  • Pre-conversion holding (as of 02/06/2026): 1,09,18,325 equity shares (62.92%)
  • Post-conversion holding: 1,11,83,325 equity shares (63.47%)
  • Increase in holding: 265,000 shares (0.55% increase)

Additional Securities Held

Bilcare Limited also holds:

  • 315,000 convertible warrants (100% of outstanding warrants)
  • 14,19,00,000 of 0.1% Non-cumulative, Non-Participating Redeemable Preference Shares (NPRPS)

Payment Structure

The total issue price of ₹200 per warrant was paid in two installments: 25% at the time of warrant allotment and 75% at the time of conversion into equity shares.

Documents Submitted

The disclosure includes Form C as required under SEBI regulations, providing detailed information about the securities transaction.